India pharma, healthcare revenue to grow steadily in Q1FY26E; EBITDA margins under pressure: Report
The report added that the pharma sector firms studied by it may witness a 11 per cent year-on-year (YoY) sales growth, driven by an 11 per cent YoY increase in the India business along with 2 per cent QoQ growth in US sales (+2 per cent YoY).
The EBITDA, which stands for Earnings Before Interest, Taxes, Depreciation, and Amortization, is a financial metric used to assess a company's profitability and operational efficiency.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
이 게임은 대부분의 TV 프로그램보다 더 재미있어요 – 게다가 무료예요.
Raid: Shadow Legends
플레이하기
Undo
The report stated that EBITDA margins for the pharma segment are expected to decrease by 42bps YoY, driven by price erosion in the US and an expected increase in research and development (R&D).
The hospital business is projected to grow by 15 per cent YoY, as muted occupancy will be partly supported by steady ARPOB, or Average Revenue Per Occupied Bed, which is a key performance indicator used in the healthcare industry to assess a hospital's financial performance.
Live Events
India's pharmaceutical market for FY 2023-24 is valued at USD 50 billion, with domestic consumption valued at USD 23.5 billion and exports valued at USD 26.5 billion.
The domestic pharma industry is considered to be the world's third-largest by volume and 14th in terms of value of production. With an extremely diversified product base covering generic drugs, bulk drugs, over-the-counter drugs, vaccines, biosimilars, and biologics, the Indian pharmaceutical industry has a strong presence at the global level.
According to National Accounts Statistics 2024, published by the Ministry of Statistics and Programme Implementation, total output for industry, i.e., Pharmaceuticals, medicinal and botanical products, is Rs. 4,56,246 crores for FY 2022-23 at constant prices, of which value added is Rs 1,75,583 crores.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
10 minutes ago
- Economic Times
Travel Food Services shares tumble 5% from peak after listing on premium
The shares of Travel Food Services, which got listed on the exchanges earlier today, has fallen by 5% from its intraday high of Rs 1,128.90 on the BSE after listing at a gain of 2.6% over the issue price of Rs 1,110. ADVERTISEMENT From its issue price, the stock has fallen by 2.12%. Travel Food Services, a prominent operator of airport-based quick service restaurants (QSRs) and lounges, made its stock market debut on Monday with a 2.38% premium on the BSE. The shares opened at Rs 1,126.20 on the BSE and Rs 1,125 on the NSE, against the issue price of Rs 1,100. The IPO saw a moderate response from investors, closing with an overall subscription of 3.03 times. The Qualified Institutional Buyer (QIB) category recorded the highest demand at 8.10 times, while retail investor participation remained subdued at just 0.73 times. The Non-Institutional Investor (NII) segment was subscribed 1.67 times, indicating cautious interest from high-net-worth investors. Travel Food Services, backed by UK-based SSP Group, operates 397 quick service restaurant outlets and lounges across 14 airports in India and three airports in Malaysia, covering major hubs such as Mumbai, Delhi, Bengaluru, and Chennai. ADVERTISEMENT The company offers a diverse food and beverage portfolio comprising 117 partner and in-house brands, serving the rising demand for food and travel services at high-traffic transit locations. Financially, the company reported stable earnings growth in FY25, supported by robust EBITDA margins of 40% and a return on equity (ROE) of 35.47%. However, concerns have been raised over the IPO's valuation, priced at a P/E multiple of 48.6 times, particularly since the offer is entirely secondary with no fresh capital being raised. ADVERTISEMENT Also read: Jane Street complies with Sebi, deposits Rs 4,843 crore in escrow account (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
New Indian Express
15 minutes ago
- New Indian Express
Robert Vadra appears before ED in Sanjay Bhandari case
NEW DELHI: Robert Vadra, the businessman husband of Congress MP Priyanka Gandhi Vadra, appeared before the Enforcement Directorate on Monday for his questioning in connection with the UK-based arms consultant Sanjay Bhandari linked money laundering case, official sources said. The businessman's statement will be recorded under the Prevention of Money Laundering Act (PMLA), they said. The 56-year-old Vadra was called by the agency to depose last month but he had sought deferment of his summons as he had to travel abroad. He is being investigated by the central probe agency in three different money laundering cases, including this one. The two others pertain to alleged irregularities in land deals. The 63-year-old Bhandari fled to London in 2016 soon after the Income-Tax department raided him in Delhi. He was recently declared a fugitive economic offender by a Delhi court. A UK court last month refused the Indian government's application seeking permission to appeal in Britain's Supreme Court against the discharge of Bhandari in an extradition case against him, virtually ruling out chances of his being brought to the country to face the law. The ED had filed a chargesheet in this case in 2023 alleging Bhandari "acquired" the 12, Bryanston Square house located in London in 2009 and got it renovated "as per the directions of Vadra and the funds for renovation were provided by Robert Vadra." Vadra has denied that he owned any London property directly or indirectly. Terming these charges as a political witch hunt against him, he has said that he was being "hounded and harassed" to subserve political ends.
&w=3840&q=100)
Business Standard
17 minutes ago
- Business Standard
National Herald case: Court reserves order on ED chargesheet cognisance
ED alleges that Gandhis held the majority 76 per cent shares in Young Indian, which fraudulently usurped the assets of AJL in exchange for a Rs 90 crore loan A Delhi court on Monday reserved its order on taking cognisance of the chargesheet filed by the Enforcement Directorate in the National Herald case. Special Judge Vishal Gogne said the matter will be heard on July 29. The Enforcement Directorate (ED) has accused Sonia Gandhi and Rahul Gandhi, late Congress leaders Motilal Vora and Oscar Fernandes, as well as Suman Dubey, Sam Pitroda and a private company, Young Indian, of conspiracy and money laundering over the fraudulent takeover of Rs 2,000 crore worth properties belonging to Associated Journals Limited (AJL), which published the National Herald newspaper. ED alleges that Gandhis held the majority 76 per cent shares in Young Indian, which fraudulently usurped the assets of AJL in exchange for a Rs 90 crore loan. The chargesheet names Sonia Gandhi and Rahul Gandhi, Sam Pitroda, Suman Dubey, Sunil Bhandari, Young Indian and Dotex Merchandise Pvt Ltd. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
